Suplemento II · Revista nº 814

98 Actual Med. 2021; 106(814). Supl2: 93- 98 Lesiones cutáneas e infección por SARS-CoV2 en pediatría | Rodríguez Benjumea M, et al. S U P L E M E N T O C O V I D - 1 9 5. Freeman EE, McMahon DE, Lipoff JE, Rosenbach M, Kova- rik C et al. The spectrum of COVID-19 – associated der- matologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020; 83 (4): 1118- 1129. 6. Caselli D, Chironna M, Loconsole D, et al. No evidence of SARS-Cov-2 infection by PCR or serology in children with pseudo chilblain. Br J Dermatol. 2020. doi: 10.1111/ bjd.19349. Online ahead of print. 7. Monte Serrano JM, Cruañes Monferrer J, Matovelle Ochoa C, García Gil MF. Lesiones cutáneas tipo perniosis durante la epi- demia COVID- 19. An Pediatr ( Barc). 2020; 92 (6): 378- 380 8. Colonna C, Genovese G, Monzani NA, Picca M, Boggio F et al. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pan- demic. J Am Acad Dermatol. 2020; 83(3): 965-969. 9. García- Lara G, Linares- González L, Ródenas- Herranz T, Ruíz- Valleverde R. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 out- break. Dermatol Ther. 2020.doi: 10.1111/dth.13516. On- line ahead of print. 10. Mastrolonardo M, Romita P, Bonifazi E, Giuffrida R, Lotti T et al. The management of the outbreak of acral skin mani- festations in asymptomatic children during COVID-19 era. Dermatol Ther. 2020; e13617. doi: 10.1111/dth.13617. On- line ahead of print. 11. Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G. Chilblain-like lesions during COVID-19 epidemic: a prelimi- nary study on 63 patients. J Eur Acad Dermatol Venereol. 2020; 34 (7): e291-e293. 12. Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A et al. Acral cutaneous lesions in the time of COVID- 19.  Eur Acad Dermatol Venereol. 2020 Aug;34(8): e346-e347. 13. Hébert V, Duval-Modeste AB, Lemée V, Joly P, Cellier L et al. Lack of association between
chilblains outbreak and severe acute respiratory syndrome coronavirus
2: Histologic and serologic findings
from a new immunoassay. J Am Acad Dermatol. 2020; 83 (5):1434-1436.
 14. Colmenero I, Santoja C, Alonso- Riaño M, Noguera- Morel L, Hernández- Martín A et al. SARS- CoV- 2 endothelial infec- tion causes COVID- 19 chilblains: histopathological, immu- nohistochemical and ultrastructural study of 7 paediatric cases. British Journal of dermatology. 2020. DOI 10.1111/ bjd.19327. Online ahead of print. 15. Morey – Olivé M, Espiau M, Mercadal- Hally M, Lera- Carba- llo E, García- Patos V. Manifestaciones cutáneas en contex- to del brote actual de enfermedad por coronavirus 2019. An Pediatr (Barc). 2020; 92 (6): 374-375. 16. Ortiz Madinaveita S, Peñalver Penedo R, Romero Gil R, Se- rrano Madrid ML. Lesiones cutáneas en paciente con infec- ción por SARS-CoV-2. An Pediatr (Barc). 2020; 93 (2): 144-145. 17. Torrelo A, Andina D, Santoja C, Noguera-Morel L, Bascuas- Arribas M, Gaitero- Tristán J et al. Erythema multiforme –like lesions in children and COVID-19. Pediatr Dermatol. 2020; 37 (3): 442-446. 18. Genovese G, Colonna C, Marzano AV. Varicella-like exan- them associated with COVID-19 in an 8- year-old girl: a diagnostic clue? Pediatr Dermatol. 2020; 37 (3): 435-436. 19. Criado PR, Abdalla BMZ, de Assis IC, van Blarcum de Graaff Mello C, Caputo GC, Vieira IC. Are the cutaneous manifes- tations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic me- chanisms. Inflamm Res. 2020; 69 (8): 745-756. 20. Jamiolkowski D, MÜhleisen B, Müller S, Navarini AA, Tzankov A, Roider E. SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report. Lancet. 2020; 396 (10251): 598-599. 21. Fiehn C. Familial chilblain lupusdwhat can we learn from type I interferonopathies? Curr Rheumatol Rep. 2017; 19:61. 22. Elena Gkrouzman, Medha Barbhaiya,   Doruk Erkan, Michael D Lockshin. A reality check on antiphospholipid antibodies in COVID-19-associated coagulopathy. Arthritis Rheumatol 2020. doi: 10.1002/art.41472. Online ahead of print. 23. Smith JA, Marker-Hermann E, Colbert RA. Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol. 2006; 20:571-91. 24. Tagarro A, Epalza E, Santos M, Sanz-Santaeufemia FJ, Otheo E, Moraleda C, Calvo C. Screening and severity of Co- ronavirus Disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr. 2020: e201346. Online ahead of print.
 25. Garcia- Basteiro AL, Moncunil G, Tortajada M, Vidal M, Gui- novart G et al. Seroprevalence of antibodies against SARS- CoV-2 among health care workers in a large Spanish refe- rence hospital. Nat Commun. 2020; 11 (1):3500. 26. Cheng MP, Yansouni CP, Basta NE, Desjardins M, Kanjilal S et al. Serodiagnostics for Severe Acute Respiratory Syndro- me-Related Coronavirus 2: A Narrative Review. Ann Intern Med. 2020; 173 (6): 450-460. Los autores/as de este artículo declaran no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. CONFLICTO DE INTERESES Si desea citar nuestro artículo: Rodríguez Benjumea M, Vázquez Pérez A, Santos Perez JL. Lesiones cutáneas e infección por SARS-CoV2 en una cohorte pediátrica de un hospital terciario. ¿Solo Covid?. Actual Med. 2021; 106(814). Supl2: 93- 98